AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2018
May 7, 2018
35066_dirs_2018-05-07_f3172feb-4180-40f9-a6c3-c2b0174d3ffe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2018-05-03
Reporting Person: Schinazi Raymond F (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-05-03 | Common Stock | A | 420737 | $1.90 | Acquired | 722226 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 929525 | Indirect |
| Common Stock | 9240928 | Direct |
More from Cocrystal Pharma, Inc.
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15